Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0I8QS
|
||||
Former ID |
DNC000339
|
||||
Drug Name |
BN82451
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Parkinson's disease [ICD9: 332; ICD10:G20] | Phase 2 | [524900] | ||
Company |
Ipsen
|
||||
Structure |
Download2D MOL |
||||
Formula |
C18H26N2OS
|
||||
Canonical SMILES |
CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C2=CSC(=N2)CN
|
||||
InChI |
1S/C18H26N2OS/c1-17(2,3)12-7-11(14-10-22-15(9-19)20-14)8-13(16(12)21)18(4,5)6/h7-8,10,21H,9,19H2,1-6H3
|
||||
InChIKey |
HAQOEWGSBVQDHB-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Sodium channel | Target Info | Blocker | [537349] | |
Cyclooxygenase | Target Info | Inhibitor | [537349] | ||
KEGG Pathway | Dopaminergic synapse | ||||
Reactome | Interaction between L1 and Ankyrins | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.